The Use of Telmisartan and the Incidence of Cancer

BACKGROUND: A meta-analysis reported an 8% increased risk of cancer with the use of angiotensin receptor blockers (ARBs), but subsequent meta-analyses and observational studies did not confirm this risk. However, telmisartan comprised 85% of the data in the original meta-analysis. Thus, the objectiv...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Hypertens
Asıl Yazarlar: Tascilar, Koray, Azoulay, Laurent, Dell’Aniello, Sophie, Bartels, Dorothee B., Suissa, Samy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863774/
https://ncbi.nlm.nih.gov/pubmed/27557862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpw095
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller